Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Dyskinesia, Drug-Induced

1-methyl-3-isobutylxanthine has been researched along with Dyskinesia, Drug-Induced in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)

Research Excerpts

ExcerptRelevanceReference
"Haloperidol treatment significantly increased dyskinetic movements and striatal dopamine D2 receptor density compared with controls."1.29Suppression of oro-facial movements by rolipram, a cAMP phosphodiesterase inhibitor, in rats chronically treated with haloperidol. ( Fukui, S; Hashimoto, K; Inada, T; Iyo, M; Sasaki, H, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sasaki, H1
Hashimoto, K1
Inada, T1
Fukui, S1
Iyo, M1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Dyskinesia, Drug-Induced

ArticleYear
Suppression of oro-facial movements by rolipram, a cAMP phosphodiesterase inhibitor, in rats chronically treated with haloperidol.
    European journal of pharmacology, 1995, Aug-25, Volume: 282, Issue:1-3

    Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Antipsychotic Agents; Dep

1995